Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

1.

Expressions of mRNA for innate immunity-associated functional molecules in urinary sediment in IgA nephropathy.

Tsuruga K, Aizawa T, Watanabe S, Tsugawa K, Yoshida H, Imaizumi T, Ito E, Tanaka H.

Nephrology (Carlton). 2015 Jun 7. doi: 10.1111/nep.12533. [Epub ahead of print]

PMID:
26058859
2.

Class I HDAC inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damage.

Fukuda T, Wu W, Okada M, Maeda I, Kojima Y, Hayami R, Miyoshi Y, Tsugawa KI, Ohta T.

Cancer Sci. 2015 Jun 6. doi: 10.1111/cas.12717. [Epub ahead of print]

PMID:
26053117
3.

[Nipple-sparing mastectomy for breast cancer].

Koike A, Tsugawa K.

Nihon Geka Gakkai Zasshi. 2015 Mar;116(2):121-2. Japanese. No abstract available.

PMID:
26050514
4.

MED12 exon 2 mutations in phyllodes tumors of the breast.

Nagasawa S, Maeda I, Fukuda T, Wu W, Hayami R, Kojima Y, Tsugawa KI, Ohta T.

Cancer Med. 2015 Apr 13. doi: 10.1002/cam4.462. [Epub ahead of print]

5.

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.

Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group.

N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513.

PMID:
25693012
6.

LSD1 overexpression is associated with poor prognosis in basal-like breast cancer, and sensitivity to PARP inhibition.

Nagasawa S, Sedukhina AS, Nakagawa Y, Maeda I, Kubota M, Ohnuma S, Tsugawa K, Ohta T, Roche-Molina M, Bernal JA, Narváez AJ, Jeyasekharan AD, Sato K.

PLoS One. 2015 Feb 13;10(2):e0118002. doi: 10.1371/journal.pone.0118002. eCollection 2015.

7.

[III. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer].

Tsugawa K, Nagasawa S.

Gan To Kagaku Ryoho. 2014 Dec;41(13):2568-70. Japanese. No abstract available.

PMID:
25668825
8.

Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial.

Aihara T, Yokota I, Hozumi Y, Aogi K, Iwata H, Tamura M, Fukuuchi A, Makino H, Kim R, Andoh M, Tsugawa K, Ohno S, Yamaguchi T, Ohashi Y, Watanabe T, Takatsuka Y, Mukai H.

Breast Cancer Res Treat. 2014 Nov;148(2):337-43. doi: 10.1007/s10549-014-3155-8. Epub 2014 Oct 16.

PMID:
25318924
9.

Long-term low carbohydrate diet leads to deleterious metabolic manifestations in diabetic mice.

Handa K, Inukai K, Onuma H, Kudo A, Nakagawa F, Tsugawa K, Kitahara A, Moriya R, Takahashi K, Sumitani Y, Hosaka T, Kawakami H, Oyadomari S, Ishida H.

PLoS One. 2014 Aug 29;9(8):e104948. doi: 10.1371/journal.pone.0104948. eCollection 2014.

10.

Positive predictive value for malignancy of pure flat epithelial atypia diagnosis by percutaneous needle biopsy of the breast: management of FEA in ultrasonography.

Maeda I, Kanemaki Y, Tozaki M, Koizumi H, Oana Y, Okanami Y, Tsuchiya K, Shimo A, Kojima Y, Hayami R, Nishikawa T, Kawamoto H, Yabuki Y, Tsugawa K, Takagi M.

Breast Cancer. 2014 Apr 24. [Epub ahead of print]

PMID:
24760612
11.

Clinicopathological significance of 'atypical ductal proliferation' in core needle biopsy of the breast.

Abe E, Suzuki K, Hayashi N, Yang Y, Li CP, Uno M, Akiyama F, Yamauchi H, Nakamura S, Tsugawa K, Tsunoda H, Ohde S, Sasano H.

Pathol Int. 2014 Feb;64(2):58-66. doi: 10.1111/pin.12135.

PMID:
24629173
12.

Aberrant DNA methylation status of DNA repair genes in breast cancer treated with neoadjuvant chemotherapy.

Watanabe Y, Maeda I, Oikawa R, Wu W, Tsuchiya K, Miyoshi Y, Itoh F, Tsugawa K, Ohta T.

Genes Cells. 2013 Dec;18(12):1120-30. doi: 10.1111/gtc.12100. Epub 2013 Oct 28.

PMID:
24581343
13.

Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.

Yagata H, Yamauchi H, Tsugawa K, Hayashi N, Yoshida A, Kajiura Y, In R, Matsuda N, Nakamura S.

Clin Breast Cancer. 2013 Dec;13(6):471-7. doi: 10.1016/j.clbc.2013.08.014.

PMID:
24267732
14.

The value of progesterone receptor expression in predicting the Recurrence Score for hormone-receptor positive invasive breast cancer patients.

Onoda T, Yamauchi H, Yagata H, Tsugawa K, Hayashi N, Yoshida A, Suzuki K, Sakurai O, Nakamura S.

Breast Cancer. 2015 Jul;22(4):406-12. doi: 10.1007/s12282-013-0495-x. Epub 2013 Oct 1.

PMID:
24081457
15.

Molecular detection of lymph node metastasis in breast cancer patients treated with preoperative systemic chemotherapy: a prospective multicentre trial using the one-step nucleic acid amplification assay.

Osako T, Tsuda H, Horii R, Iwase T, Yamauchi H, Yagata H, Tsugawa K, Suzuki K, Kinoshita T, Akiyama F, Nakamura S.

Br J Cancer. 2013 Sep 17;109(6):1693-8. doi: 10.1038/bjc.2013.503. Epub 2013 Sep 3.

16.

[Clinical significance of sentinel lymph node micrometastases in invasive breast carcinoma].

Tsugawa K.

Nihon Geka Gakkai Zasshi. 2013 Jan;114(1):22-7. Japanese.

PMID:
23457941
17.

Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence.

Yoshida A, Hayashi N, Akiyama F, Yamauchi H, Uruno T, Kikuchi M, Yagata H, Tsugawa K, Suzuki K, Nakamura S, Tsunoda H.

Clin Breast Cancer. 2012 Dec;12(6):398-403. doi: 10.1016/j.clbc.2012.08.002. Epub 2012 Oct 17.

PMID:
23083502
18.

Pathological assessment of microinvasive carcinoma of the breast.

Mori M, Tsugawa K, Yamauchi H, Yagata H, Suzuki K, Ohde S, Soejima K, Nakamura S.

Breast Cancer. 2013 Oct;20(4):331-5. doi: 10.1007/s12282-012-0339-0. Epub 2012 Mar 7.

PMID:
22396321
19.

Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: results of a multicenter study in Japan.

Tamaki Y, Sato N, Homma K, Takabatake D, Nishimura R, Tsujimoto M, Yoshidome K, Tsuda H, Kinoshita T, Kato H, Taniyama K, Kamio T, Nakamura S, Akiyama F, Noguchi S; Japanese One-Step Nucleic Acid Amplification Study Group.

Cancer. 2012 Jul 15;118(14):3477-83. doi: 10.1002/cncr.26683. Epub 2012 Jan 17.

20.

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group.

N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk